Cargando…
Haemoperfusion should only be used for COVID-19 in the context of randomized trials
Interest in the use of haemoperfusion for severe COVID-19 has been spurred by anecdotal reports of its efficacy and expert reviews suggesting theoretical benefits. However, on the basis of the limited current evidence, haemoperfusion remains an experimental therapy that should only be applied within...
Autores principales: | Clark, Edward G., Hiremath, Swapnil, McIntyre, Lauralyn, Wald, Ron, Hundemer, Gregory L., Joannidis, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478103/ https://www.ncbi.nlm.nih.gov/pubmed/32901129 http://dx.doi.org/10.1038/s41581-020-00352-9 |
Ejemplares similares
-
Intravenous albumin for the prevention of hemodynamic instability during sustained low-efficiency dialysis: a randomized controlled feasibility trial (The SAFER-SLED Study)
por: Clark, Edward G., et al.
Publicado: (2021) -
Interventions to prevent hemodynamic instability during renal replacement therapy for acute kidney injury: a systematic review protocol
por: Douvris, Adrianna, et al.
Publicado: (2017) -
Interventions to prevent hemodynamic instability during renal replacement therapy in critically ill patients: a systematic review
por: Douvris, Adrianna, et al.
Publicado: (2018) -
Management of severe theophylline overdosage by charcoal haemoperfusion.
por: Uprichard, A. C., et al.
Publicado: (1984) -
The effect of endotoxin adsorber haemoperfusion on microcirculation in septic pigs
por: Yeh, Y-C, et al.
Publicado: (2015)